96 related articles for article (PubMed ID: 30663656)
1. Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence.
Kesarwani M; Kincaid Z; Azam M
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30663656
[TBL] [Abstract][Full Text] [Related]
2. Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia.
Kesarwani M; Kincaid Z; Gomaa A; Huber E; Rohrabaugh S; Siddiqui Z; Bouso MF; Latif T; Xu M; Komurov K; Mulloy JC; Cancelas JA; Grimes HL; Azam M
Nat Med; 2017 Apr; 23(4):472-482. PubMed ID: 28319094
[TBL] [Abstract][Full Text] [Related]
3. The role of Fas-associated phosphatase 1 in leukemia stem cell persistence during tyrosine kinase inhibitor treatment of chronic myeloid leukemia.
Huang W; Luan CH; Hjort EE; Bei L; Mishra R; Sakamoto KM; Platanias LC; Eklund EA
Leukemia; 2016 Jul; 30(7):1502-9. PubMed ID: 26984787
[TBL] [Abstract][Full Text] [Related]
4. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers.
Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC
Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344
[TBL] [Abstract][Full Text] [Related]
5. Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.
Pietarinen PO; Eide CA; Ayuda-Durán P; Potdar S; Kuusanmäki H; Andersson EI; Mpindi JP; Pemovska T; Kontro M; Heckman CA; Kallioniemi O; Wennerberg K; Hjorth-Hansen H; Druker BJ; Enserink JM; Tyner JW; Mustjoki S; Porkka K
Oncotarget; 2017 Apr; 8(14):22606-22615. PubMed ID: 28186983
[TBL] [Abstract][Full Text] [Related]
6. Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors.
Wöhrle FU; Halbach S; Aumann K; Schwemmers S; Braun S; Auberger P; Schramek D; Penninger JM; Laßmann S; Werner M; Waller CF; Pahl HL; Zeiser R; Daly RJ; Brummer T
Leukemia; 2013 Jan; 27(1):118-29. PubMed ID: 22858987
[TBL] [Abstract][Full Text] [Related]
7. ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia.
Pigazzi M; Manara E; Beghin A; Baron E; Tregnago C; Basso G
Clin Cancer Res; 2011 Feb; 17(4):742-52. PubMed ID: 21325296
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine Kinase Inhibitors in Ph+ Chronic Myeloid Leukemia Therapy: a Review.
Shah K; Parikh S; Rawal R
Asian Pac J Cancer Prev; 2016; 17(7):3025-33. PubMed ID: 27509925
[TBL] [Abstract][Full Text] [Related]
9. Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.
Zhu Y; Lu L; Qiao C; Shan Y; Li H; Qian S; Hong M; Zhao H; Li J; Yang Z; Chen Y
Oncogene; 2018 May; 37(21):2837-2849. PubMed ID: 29511345
[TBL] [Abstract][Full Text] [Related]
10. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
[TBL] [Abstract][Full Text] [Related]
11. Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy.
Kim T; Tyndel MS; Zhang Z; Ahn J; Choi S; Szardenings M; Lipton JH; Kim HJ; Kim Dong Hwan D
Leuk Res; 2017 Aug; 59():142-148. PubMed ID: 28667884
[TBL] [Abstract][Full Text] [Related]
12. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
Ferri C; Bianchini M; Bengió R; Larripa I
Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
[TBL] [Abstract][Full Text] [Related]
13. Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells.
Wu L; Yu J; Chen R; Liu Y; Lou L; Wu Y; Huang L; Fan Y; Gao P; Huang M; Wu Y; Chen Y; Xu J
Clin Cancer Res; 2015 Feb; 21(4):833-43. PubMed ID: 25501124
[TBL] [Abstract][Full Text] [Related]
14. Suppression of dual specificity phosphatase I expression inhibits hepatitis C virus replication.
Choi JE; Kwon JH; Kim JH; Hur W; Sung PS; Choi SW; Yoon SK
PLoS One; 2015; 10(3):e0119172. PubMed ID: 25798824
[TBL] [Abstract][Full Text] [Related]
15. [Protein phosphatase MKP-1 participates in c-fos gene derepression under the action of stress factors on fibroblasts transformed with E1A and cHA-ras oncogenes].
Kukushkin AN; Svetlikova SB; Pospelov VA
Tsitologiia; 2013; 55(12):861-7. PubMed ID: 25474904
[TBL] [Abstract][Full Text] [Related]
16. Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids.
Maier JV; Brema S; Tuckermann J; Herzer U; Klein M; Stassen M; Moorthy A; Cato AC
Mol Endocrinol; 2007 Nov; 21(11):2663-71. PubMed ID: 17636038
[TBL] [Abstract][Full Text] [Related]
17. Use of tyrosine kinase inhibitors for chronic myeloid leukemia: management of patients and practical applications for pharmacy practitioners.
Wong SF; Mirshahidi H
Ann Pharmacother; 2011 Jun; 45(6):787-97. PubMed ID: 21672900
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.
Chamseddine AN; Willekens C; De Botton S; Bourhis JH
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S129-40. PubMed ID: 26297265
[TBL] [Abstract][Full Text] [Related]
19. MAP kinase phosphatase DUSP1 is overexpressed in obese humans and modulated by physical exercise.
Khadir A; Tiss A; Abubaker J; Abu-Farha M; Al-Khairi I; Cherian P; John J; Kavalakatt S; Warsame S; Al-Madhoun A; Al-Ghimlas F; Elkum N; Behbehani K; Dermime S; Dehbi M
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E71-83. PubMed ID: 25370852
[TBL] [Abstract][Full Text] [Related]
20. Differential genomics and transcriptomics between tyrosine kinase inhibitor-sensitive and -resistant BCR-ABL-dependent chronic myeloid leukemia.
Singh N; Tripathi AK; Sahu DK; Mishra A; Linan M; Argente B; Varkey J; Parida N; Chowdhry R; Shyam H; Alam N; Dixit S; Shankar P; Mishra A; Agarwal A; Yoo C; Bhatt MLB; Kant R
Oncotarget; 2018 Jul; 9(54):30385-30418. PubMed ID: 30100996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
